Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2019

Aug 30, 2019

3535_iss_2019-08-30_ed909ab7-0fd9-4bc7-a67b-f7eb66a727aa.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology Asa: Exercise Period Ending on 1 September 2019

Aqua Bio Technology Asa: Exercise Period Ending on 1 September 2019

Reference is made to the stock exchange notice of Aqua Bio Technology ASA ("ABT"

or the "Company") published on 14 February 2019, regarding independent

subscription rights issued by the Company ("Warrants").

The exercise period for the Warrants ends on 1 September 2019, and exercise

notices may be received by the Company until the end of that date. Warrants that

are not exercised within the end of 1 September 2019 will lapse automatically

without compensation to the holder.

Each Warrant gives the holder a right to subscribe for one (1) share in the

Company at a subscription price of NOK 2.50 per share.

Holders of Warrants who wish to exercise these may do so by providing written

notice to the Company, on the following address:

Aqua Bio Technology ASA

Fornebuveien 37

1366 Lysaker

Norway

E-mail: [email protected]

Investors who require issuance of shares through exercise of Warrants shall

receive these as effectively as practically possible after 1 September 2019. The

Company will provide payment information for share deposits following exercise

of Warrants.

For further information, please contact Edvard Cock, Chairman of the Board,

telephone +47 415 04 004 or [email protected]

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on the Axess market of the

Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.